Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Part of this new funding will help the Dementias Platform UK team work with the MND community to translate scientific discoveries into real-world treatments.

DPUK logo

Dementias Platform UK, based in Oxford's Department of Psychiatry, welcomes the government’s announcement of £50 million into Motor Neurone Disease (MND) research.

The pledge of £3 million investment by the Medical Research Council towards a translational accelerator,  matched by £3 million from the National Institute for Health and Care Research, will enable the MND community to work in partnership with Dementias Platform UK and the UK Dementia Research Institute.

Read more about the story on the Dementias Platform UK website 

 

Similar stories

Alan Davidson Foundation renews funding for ground-breaking motor neuron disease research at Oxford

As part of its renewed commitment, the Alan Davidson Foundation will continue to fund a full-time project manager to facilitate the ongoing coordination and growth of the ACORN study. The foundation is also contributing to the cost of a research fellow to support the next phase of the project.